These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16581251)

  • 1. The preponderance of P450s in the Mycobacterium tuberculosis genome.
    McLean KJ; Clift D; Lewis DG; Sabri M; Balding PR; Sutcliffe MJ; Leys D; Munro AW
    Trends Microbiol; 2006 May; 14(5):220-8. PubMed ID: 16581251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen.
    McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.
    McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW
    Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodiversity of cytochrome P450 redox systems.
    McLean KJ; Sabri M; Marshall KR; Lawson RJ; Lewis DG; Clift D; Balding PR; Dunford AJ; Warman AJ; McVey JP; Quinn AM; Sutcliffe MJ; Scrutton NS; Munro AW
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):796-801. PubMed ID: 16042601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.
    McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW
    Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?
    Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC
    Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems.
    McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW
    Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of Mycobacterium tuberculosis CYP144: common themes and lessons learned in the M. tuberculosis P450 enzyme family.
    Driscoll MD; McLean KJ; Cheesman MR; Jowitt TA; Howard M; Carroll P; Parish T; Munro AW
    Biochim Biophys Acta; 2011 Jan; 1814(1):76-87. PubMed ID: 20621636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
    McLean KJ; Munro AW
    Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
    Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
    J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
    Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
    Kavanagh ME; Chenge J; Zoufir A; McLean KJ; Coyne AG; Bender A; Munro AW; Abell C
    Biochemistry; 2017 Mar; 56(11):1559-1572. PubMed ID: 28169518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium.
    Ortega Ugalde S; Luirink RA; Geerke DP; Vermeulen NPE; Bitter W; Commandeur JNM
    J Inorg Biochem; 2018 Mar; 180():47-53. PubMed ID: 29232638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.
    McLean KJ; Warman AJ; Seward HE; Marshall KR; Girvan HM; Cheesman MR; Waterman MR; Munro AW
    Biochemistry; 2006 Jul; 45(27):8427-43. PubMed ID: 16819841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target].
    Lu Y; Qiao F; You XF; Yang XY
    Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.
    McLean KJ; Cheesman MR; Rivers SL; Richmond A; Leys D; Chapman SK; Reid GA; Price NC; Kelly SM; Clarkson J; Smith WE; Munro AW
    J Inorg Biochem; 2002 Sep; 91(4):527-41. PubMed ID: 12237220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and mass spectrometric tools for elucidating the physiological function(s) of cytochrome P450 enzymes from Mycobacterium tuberculosis.
    Ouellet H; Chow ED; Guan S; Cox JS; Burlingame AL; de Montellano PR
    Methods Mol Biol; 2013; 987():79-94. PubMed ID: 23475669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QM/MM study of the C-C coupling reaction mechanism of CYP121, an essential cytochrome p450 of Mycobacterium tuberculosis.
    Dumas VG; Defelipe LA; Petruk AA; Turjanski AG; Marti MA
    Proteins; 2014 Jun; 82(6):1004-21. PubMed ID: 24356896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.